Correspondence: When an article is eligible for submission of
Correspondence, a link to the response form is available within the full-text
article. You must be a
current subscriber who has activated the online portion of your subscription
in order to send a Correspondence. Any reader can read published
Correspondence.
Correspondence to:
BRIEF COMMUNICATIONS:
R. J. Hagerman, M. Leehey, W. Heinrichs, F. Tassone, R. Wilson, J. Hills, J. Grigsby, B. Gage, and P. J. Hagerman
Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X
Neurology 2001; 57: 127-130
[Abstract][Full text][PDF]
randi.hagerman{at}ucdmc.ucdavis.edu RJ Hagerman, et al.
Dear Editor:
We are aware of the Desai [1] study of a man with
fragile X syndrome (FXS) who also had ALS. This case appears to be the coincidental
occurrence of ALS in a patient with FXS. Previous neuropathological
reports in FXS have shown limited neuronal cell loss and gliosis [2], although neuronal cell death in the substantia nigra
has not previously been reported in FXS. There is evidence, however, of
shrinkage of the temporal lobes and dilation of the ventricles with age
that is more remarkable in FXS compared to what is seen in controls [3]. Further neuroanatomical studies in those with the full
mutation and those with the premutation are needed.
There are no reports of neurodegeneration in patients with the full
FXS with ALS other than the case reported by Desai [1].
In contrast, the neurological syndrome in older men with the premutation
that we reported [4] has been observed in other cases. We have since seen this tremor ataxia syndrome in nine other men and have the medical records on an additional eight cases
who died after a neurodegenerative course. Further epidemiology
studies are needed to clarify the prevalence of this problem in both men
and women with the premutation. It is unclear whether this
condition is related to the elevated mRNA in these males but studies are
in progress. The neuropathology in
this tremor/ataxia syndrome are also being examined. There is no megalencephaly or loss of
neurons in the substantia nigra, indicating a different mechanism of
pathogenesis than what was reported or discussed by
Munoz.
References:
1. Desai HB,Donat J, Shokeir MH, Munoz DG. Amyotrophic lateral
sclerosis in a patient with fragile X syndrome. Neurology 1990; 40:378-80.
2.
Sabaratnam M. Pathological and neuropathological findings in two males with fragile X syndrome. J Intell Disabil Res 2000; 44:81-85.
3. Reiss AL, Abrams MT, Greenlaw R, Freund L, Denckla MB.
Neurodevelopmental effects of the FMR-1 full mutation in humans. Nature
Medicine 1995; 1:159-67.
4. Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J,
Grigsby J, Gage B, Hagerman PJ. Intention tremor, parkinsonism, and
generalized brain atrophy in male carriers of fragile X. Neurology 2001; 57:127-
130.
Adult-onset neurodegeneration in Fragile X syndrome
15 October 2001
David G Munoz, Neurologist Hospital Ruber Internacional, Madrid, Spain
Hagerman et al have described a syndrome characterized by intention
tremor, parkinsonism, executive function disturbances, and generalized
brain atrophy in male carriers of the fragile X syndrome [1]. Autopsies were
not available. It may be of interest to consider a previous
report of a progressive neurodegenerative disease of adult
onset in a patient with the characteristic fragile X phenotype and
cytogenetically proven fragile X chromosome. At age 39 this man developed
dysarthria and spasticity, and by age 40 he was anarthic and unable to
stand. In addition to muscle atrophy, fasciculations, increased tone and
hyperreflexia, examination showed focal and generalized myoclonic jerks.
There was generalized slowing on EEG and cerebral atrophy on CT scan.
Autopsy, obtained after death at age 41, showed typical features of
amyotrophic lateral sclerosis (ALS), along with megalencephaly (1850 g),
evidence of neuronal death in the substantia nigra, and loss of small
neurons and gliosis in the neostriatum . Clinical and pathological
diagnosis was ALS with atypical features [2]. Thus, both male carriers and
patients expressing the full fragile X syndrome can develop
neurodegenerative diseases as adults and those diseases may not fit neatly into established
categories. By analogy with the fragile X patient, it can be predicted
that histological examination of the brains of the fragile X carriers
reported by Hagerman et al. will show neuronal loss and gliosis in the
absence of beta-amyloid, tau, or alpha-synuclein deposition. This raises questions concerning shared pathogenetic mechanisms among the
several neurodegenerative diseases and the role of elevated FMR1 messenger
RNA in their development.
Reference List
1. Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J
et al. Intention tremor, parkinsonism, and generalized brain atrophy in
male carriers of fragile X. Neurology 2001; 57:127-130.
2. Desai HB, Donat J, Shokeir MH, Munoz DG. Amyotrophic lateral
sclerosis in a patient with fragile X syndrome. Neurology 1990; 40:378-
380.